Trial Profile
A Study to Investigate Potential Interactions Between GSK598809 and Ethanol in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2023
Price :
$35
*
At a glance
- Drugs GSK 598809 (Primary)
- Indications Eating disorders; Smoking withdrawal; Substance-related disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 15 May 2014 New trial record